Follicular Lymphoma
Showing NaN - NaN of 42
Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)
Terminated
- Follicular Lymphoma
- Mantle Cell Lymphoma
-
New York, New YorkWeill Cornell Medicine
Sep 20, 2021
Follicular Lymphoma Trial in New York (TGR-1202)
Terminated
- Follicular Lymphoma
-
New York, New YorkColumbia University Medical Center
Jun 28, 2021
Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)
Recruiting
- Cancer, Metastatic
- +42 more
- Clinical Trial Matching
-
New York, New YorkMassive Bio, Inc
May 21, 2021
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib
Terminated
- Chronic Lymphocytic Leukemia
- +4 more
- Entospletinib MM
- Entospletinib SDD
-
Birmingham, Alabama
- +47 more
Nov 2, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Follicular Lymphoma, DLBCL Trial in Worldwide (Obinutuzumab, Pinatuzumab Vedotin, Polatuzumab Vedotin)
Completed
- Follicular Lymphoma
- Diffuse Large B-Cell Lymphoma
- Obinutuzumab
- +3 more
-
Los Angeles, California
- +40 more
Feb 20, 2020
Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)
Completed
- Follicular Lymphoma
- +3 more
-
Fullerton, California
- +40 more
Jun 14, 2019
Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)
Completed
- Follicular Lymphoma
- +2 more
-
Burbank, California
- +11 more
Mar 26, 2019
Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Palo Alto, New York (Idelalisib)
Completed
- Indolent Non-Hodgkin's Lymphoma
- +3 more
-
Palo Alto, California
- +1 more
Oct 19, 2018
Follicular Lymphoma Trial in New York (90Y-epratuzumab tetraxetan, veltuzumab)
Terminated
- Follicular Lymphoma
- 90Y-epratuzumab tetraxetan
- veltuzumab
-
New York, New YorkWeill Cornell Medical College
Jan 26, 2018